Anaptysbio, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
AnaptysBio, Inc. has announced its 2026 Annual Meeting of Stockholders will be held on August 11, 2026, to elect directors, ratify auditors, vote on executive compensation, and approve an amendment to its equity incentive plan.
NASDAQ
AnaptysBio, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
AnaptysBio announces its 2025 Annual Meeting of Stockholders to be held on June 17, 2025, including proposals for director elections, auditor ratification, executive compensation, and an amendment to the 2017 Equity Incentive Plan.
NASDAQ
AnaptysBio, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
AnaptysBio announces its 2024 Annual Meeting of Stockholders to be held on June 12, 2024, outlining proposals for director elections, auditor ratification, executive compensation advisory vote, and equity incentive plan amendment.